Menu

About Us
GeM Registration
Company Insights

Department of Military Affairs Tender by Indian Army (GEM/2025/B/6154087)

Carbidopa 18.75 Plus Levodopa 75 mg Plus Entacapone 200 mg tab,Carbidopa 25 mg Plus Levodopa 100 mg

Dehradun, Uttarakhand
Goods
Qty:2.7L
Department of Military Affairs Tender by Indian Army (GEM/2025/B/6154087)

Tender Timeline

Tender Issue
April 30, 2025 at 9:03 AM

Tender Title: BOQECHSIFARE18
Tender Reference Number: GEM/2025/B/6154087
Issuing Authority: Department of Military Affairs, Ministry of Defence

Scope of Work and Objectives

The Department of Military Affairs under the Ministry of Defence is inviting bids for the supply of specific pharmaceutical products, including Carbidopa 18.75 mg Plus Levodopa 75 mg Plus Entacapone 200 mg, Carbidopa 25 mg Plus Levodopa 100 mg, and Cilnidipine 10 mg Tabs. The total quantity to be supplied is 273,535 units, which includes multiple variations of the specified medications. Bidders are required to ensure that the products meet the necessary regulatory standards and are delivered to designated locations as specified by the Department.

Eligibility Criteria

To be eligible to participate in this tender, bidders must meet the following eligibility criteria:

  1. Bidders must be registered pharmaceutical suppliers or manufacturers.
  2. Compliance with all applicable laws and regulations governing the pharmaceutical sector.
  3. Previous experience in supplying similar medical products is highly desirable.

Technical Requirements

Bidders are expected to adhere to stringent technical requirements, which include, but are not limited to:

  • All medications must comply with the latest pharmacopoeia standards.
  • Submission of certificates of quality assurance and efficacy for the products being supplied.
  • Provision of detailed product specifications and labeling information.

Financial Requirements

Interested bidders should be prepared to demonstrate their financial stability and capacity to handle a supply order of this magnitude. Financial statements and any other required documents will need to be included with the bid submission.

Document Submission Details

All documentation must be submitted electronically via the designated bidder portal. Bidders should include:

  • Technical bids containing specifications and compliance documents.
  • Financial bids, including pricing and payment terms.
  • Earnest Money Deposit (EMD) as specified by the tender requirements.

Special Provisions

This tender may contain special provisions aimed at facilitating participation from Micro, Small, and Medium Enterprises (MSEs) and startups. Specific benefits or relaxations applicable to these categories will be announced alongside the tender documentation.

Evaluation Process

The evaluation of bids will follow a structured process based on the criteria outlined in the tender documents. The evaluation process will focus on:

  • Compliance with technical specifications
  • Financial viability
  • Delivery schedules

Bidders may be required to provide presentations or demonstrations as part of the evaluation.

Delivery Locations

The successful bidder will be responsible for making deliveries to designated military healthcare facilities as specified in the tender documentation. Delivery timelines will be strictly monitored, and penalties may be imposed for delays.

Contact Information

For further inquiries or clarifications, bidders are encouraged to contact the Department of Military Affairs directly through the official communication channels provided in the tender documentation.

Tender BOQ Items

9 Items
1.

Carbidopa 18.75 Plus Levodopa 75 mg Plus Entacapone 200 mg tab

Carbidopa 18.75Plus Levodopa 75 mg Plus Entacapone 200 mg tab

Qty:3900
Unit:no
30
2.

Carbidopa 25 mg Plus Levodopa 100 mg CR tab

Qty:19255
Unit:no
30
3.

Cilnidipine 10 mg Tab

Qty:201120
Unit:no
30
4.

Clindamycin phosphate 1Percent topical gel tube of 10 gm

Qty:3126
Unit:tube
30
5.

Calamine Lotion Bott of 100 ml

Qty:624
Unit:bottle
30
6.

Tab Capecitabine 700 mg Plus Cyclophosphamide 30 mg

Qty:360
Unit:no
30
7.

Carbamazepine 200 mg CR Tab

Qty:12750
Unit:no
30
8.

Carbamazepine 200 mg Tab

Qty:24060
Unit:no
30
9.

Budesonide 1 mg Respules

Qty:8340
Unit:amp
30

General Information

Item Category
Carbidopa 18.75 Plus Levodopa 75 mg Plus Entacapone 200 mg tab , Carbidopa 25 mg Plus Levodopa 100 mg CR tab , Cilnidipine 10 mg Tab , Clindamycin phosphate 1Percent topical gel tube of 10 gm , Calamine Lotion Bott of 100 ml , Tab Capecitabine 700 mg Plus Cyclophosphamide 30 mg , Carbamazepine 200 mg CR Tab , Carbamazepine 200 mg Tab , Budesonide 1 mg Respules
Ministry Name
Ministry of Defence
Department Name
Department of Military Affairs
Organisation Name
Indian Army
State
Uttarakhand
City
Dehradun

Financial Information

Bid Offer Validity
180 (Days)

Evaluation and Technical Information

Inspection Required
No

Tender Documents

6 Documents
GeM-Bidding-7755208.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
Other DocumentsOTHER
Buyer uploaded ATC documentATC ATC
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Similar Tenders

View All

D IFA RE 24 Cycloserine 250 mg Cap,D IFA RE 24 Fluticasone propionate lotion 0 DOT 05 bott of 10 ml

₹6.00
GEM
Goods
Qty:19.3K
6 Files
Indian Army
DARJEELING, WEST BENGAL
Boq › Boql
D IFA RE 24 Cycloserine 250 mg Cap , D IFA RE 24 Fluticasone propionate lotion 0 DOT 05 bott of 10 ml , D IFA RE 24 Fluticasone propionate inhaler for paed use 50mcg dose 120 metered doses , D IFA RE 24 Fluticasone Propionate Inhaler for Adults 125 mcg dose , D IFA RE 24 Salmeterol 50 mcg plus Fluticasone 250 mcg multi dose dry powder inhaler of 60 doses , D IFA RE 24 Salmeterol Rotacap 50mcg , D IFA RE 24 Theophylline SR 400 mg Tab , D IFA RE 24 Fexofenadine Hydrochloride Tab 120 mg , D IFA RE 24 Glucosamine 250 mg plus Chondroitin Sulphate 200 mg Cap , D IFA RE 24 Immunoglobulin Intravenous 2 DOT 5 gm Inj , D IFA RE 24 Ibuprofen Gel tube of 20 gm , D IFA RE 24 Leflunomide 20 mg Tab , D IFA RE 24 Naproxen gel tube of 20 gm , D IFA RE 24 Nimesulide gel tube of 20 gm , D IFA RE 24 Amoxycillin oral susp containing Amoxycillin base 125 mg per 5 ml after reconstitution bottle of 30 ml , D IFA RE 24 Amikacin Sulphate 250 mg 2 ml Inj , D IFA RE 24 Norfloxacin 400 mg Tab , D IFA RE 24 Ofloxacin 200 mg Tab , D IFA RE 24 Sulphamethoxazole 200 mg and Trimethoprim 40 mg per 5 ml bottle of 50 60 ml suspension , D IFA RE 24 Sulphamethoxazole 400 mg and Trimethoprim 80 mg Tab , D IFA RE 24 Acyclovir 250 mg Inj , D IFA RE 24 Acyclovir Syp 400 mg 5 ml , D IFA RE 24 Linezolid 2 mg ml 300 ml Inj , D IFA RE 24 Oseltamivir 75 mg Cap , D IFA RE 24 Brimonidine 0 DOT 2 and Brinzolamide 1 Eye Drop Bott of 5ml , D IFA RE 24 Nepafenac mocronised suspension 0 DOT 1 BAK free in 5 ml bottle , D IFA RE 24 Nitroglycerine Glyceryltrinitrate 5mg Inj , D IFA RE 24 Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 ml bottle , D IFA RE 24 Methotrexate 15mg Tab , D IFA RE 24 Paroxetine 25mg Tab , D IFA RE 24 Baclofen XL 30 mg Tab , D IFA RE 24 Clozapine 50 mg Tab , D IFA RE 24 Thiamine 100mg ml Inj 2ml Amp , D IFA RE 24 MDI spacer with mask and fish mouth valve for pediatrics set , D IFA RE 24 Fluticasone Propionate and Formoterol 120 MDI , D IFA RE 24 Cabergoline 0 DOT 25mg Tab , D IFA RE 24 Misoprostol 600mcg Tab , D IFA RE 24 Diclofenac 75mg ml Inj 1ml Amp for IV bolus , D IFA RE 24 Silicone Ring Vaginal Pessary , D IFA RE 24 Cell Culture Rabies Vaccine vial of 1 ml , D IFA RE 24 Test Mantoux Sufficent for 10 tests , D IFA RE 24 Airway long transparent Oropharyngeal set consisting of size Length 000 3 DOT 5 00 5 DOT 0 0 5 DOT 0 1 7 DOT 0 2 9 DOT 0 3 10 DOT 0 4 1 DOT 0 , D IFA RE 24 Adhesive Incise drape 50 x 45 cm , D IFA RE 24 Apparatus Anaesthetic facemask with air cushion transparent size 0 infant , D IFA RE 24 Apparatus Anaesthetic facemask with air cushion transparent size 1 paediatric , D IFA RE 24 Apparatus Anaesthetic facemask Antistatic with air cushion transparent size 3 adult with valve , D IFA RE 24 Apparatus Anaesthetic facemask Antistatic with air cushion transparent size 4
April 30, 2025
May 22, 2025 at 10:00 AM
View Details

D IFA22 Caffeine Citrate 20 mgml Inj 1ml vial,D IFA22 Salmeterol 25 mcg plus Fluticasone 125 mg MDI

GEM
Goods
Qty:26.4K
6 Files
Indian Army
DARJEELING, WEST BENGAL
Boq › Boql
D IFA22 Caffeine Citrate 20 mgml Inj 1ml vial , D IFA22 Salmeterol 25 mcg plus Fluticasone 125 mg MDI 120 doses , D IFA22 Caffeine Citrate 20mgml Oral Solution 1ml Syp , D IFA22 Fluconazole 10 mgml 30 ml Syp , D IFA22 Linezolid dry powder 100mg30ml , D IFA22 Frusemide 10 mgml 30 ml Syp , D IFA22 Domperidone Syp 1 mgml bott of 30 ml , D IFA22 Dicyclomine drops of 15 ml , D IFA22 Norflox Syp 100mg5ml bott of 30 ml , D IFA22 Phenobarbitone Syp 20 mg5 ml bott of 60 ml , D IFA22 Prednisolone Syp 5mg5ml in bott of 30 ml , D IFA22 Roxithromycin 50mg5ml Syp in bott of 30 ml , D IFA22 Natural Surfactant 25 to 80mgml Inj , D IFA22 Triclofos Syp 500 mg5ml in 30ml bottle , D IFA22 Human Milk fortifier 2 gm sachet , D IFA22 Calcium Phosphate 80 mg5 ml Syp 200ml bott , D IFA22 Bupropion HCl 150 mg SR Tab , D IFA22 Buspirone HCl 10 mg Tab , D IFA22 Clonazepam 0dot5 mg Tab , D IFA22 Clomipramine HCl 25 mg Tab , D IFA22 Doxepin HCl 75 mg Cap , D IFA22 Fluoxetine HCl 20 mg Cap , D IFA22 Haloperidol decanoate 50 mgml Inj in 1ml amp , D IFA22 Imipramine 25 mg Tab , D IFA22 Lithium Carbonate 300 mg CapTab , D IFA22 Memantine 5 mg Tab , D IFA22 Aripiprazole 10 mg Tab , D IFA22 Zolpidem 10 mg Tab , D IFA22 Quetiapine 50 mg Tab , D IFA22 Paroxetine XR 12dot5 Tab , D IFA22 Amisulpride 200mg Tab , D IFA22 Theophylline anhydrous syrup 60 mg in 5 ml as 100ml bottledot , D IFA22 Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg per metred dose in CFC free MDI , D IFA22 Salmeterol 50 mcg plus Fluticasone 500 mcg Accuhaler , D IFA22 Cough Syrup Each 5 ml contains Chlorpheniramine Maleate IP 3 mg Ammonium Chloride IP 110 mg Sodium Citrate IP 46 mg Menthol IP 0dot9 mg Bott of 110 ml , D IFA22 Cough expectorant syp 5 ml containingDiphenhydramine HCl 14dot08mg AmmoniumChloride 0dot138 gm Sodium Citrate 57dot03mg Menthol 1dot14 mg in flavoured syp basebott of 100 110 ml , D IFA22 Codeine Phosphate 10 mg plus Chlorpheniramine Maleate 4 mg per 5 ml Syp bottle of 100 ml , D IFA22 Disodium Hydrogen Citrate Syp Bott of 100ml , D IFA22 Antimicrobial Hand Gel Containing Ethyl Alcohol 60prcntge plus Cyclomethicone C1215 Alkyl Lactate plus Cetyl Lactate plus Phenoxyethanol plus Stearyl Alcohol with moisturizer , D IFA22 Anti phlebitis cream Tube of 15 g20 g , D IFA22 Haemostatic sponge gelatin 80 mm long 50mm broad 10 mm thick , D IFA22 Desmopressin Nasal spray 0dot1 mgml in vial of 2dot5 ml , D IFA22 Vit B1 50 mg Inj , D IFA22 Vitamin A solution IP 50 ml , D IFA22 Calcium 9 mg plus Calcium gluconate 50 mg Inj for IV use 10 ml Injection , D IFA22 Iron Syp Paediatric each 5 ml containing elemental Iron 2550 mg and Folic Acid 500 mcg bottle of 200 ml , D IFA22 Multi Vit Inj IV 210 ml with minimum constituents having Thiamine B130mgml Pyridoxine B6 30mgml and B12 Cyanocobalamin300 mcgml , D IFA22 Niacin 500mg Tab , D IFA22 Drop VitaminD3 Cholecalciferol 200 IUml , D IFA22 Dapagliflozin 5 mg plus Metformin 1000 mg IR Tab
April 30, 2025
May 22, 2025 at 10:00 AM
View Details

D IFA RE 21 Human Insulin Analogue Long acting basal Inj 100 IU ml Recombinant DNA origin 300 IU Di

₹158.00
GEM
Goods
Qty:11.6K
6 Files
Indian Army
DARJEELING, WEST BENGAL
Boq › Boql
D IFA RE 21 Human Insulin Analogue Long acting basal Inj 100 IU ml Recombinant DNA origin 300 IU Disposable Pen with 5 needles per pen , D IFA RE 21 Gliclazide MR 30 mg Tab , D IFA RE 21 Glipizide 5mg Tab , D IFA RE 21 Sitagliptin 50 mg Metformin 1000 mg Tab , D IFA RE 21 Insulin Lispro Biphasic injection I DOT P 25 Insulin Lispro and 75 Insulin Lispro protamine suspension , D IFA RE 21 Sirolimus 1mg Tab , D IFA RE 21 Pioglitazone Hydrochloride 15mg Tab , D IFA RE 21 Alendronate Sodium 70mg Tab , D IFA RE 21 Neostigmine 0 DOT 5mg 1ml Inj , D IFA RE 21 Cisatracurium 2 mg ml Inj 10ml vial , D IFA RE 21 Tacrolimus 1mg Prolonged Release Cap , D IFA RE 21 Mycophenolate Mofetil 750mg Tab , D IFA RE 21 Intravenous Immunoglobulin IvIg 10gm Bott of 50ml , D IFA RE 21 Calcium Phosphate 0 DOT 24 mg 5 ml Syp , D IFA RE 21 Calcium Acetate 500 mg Tab , D IFA RE 21 Carnitine 200 mg Tab , D IFA RE 21 Acyclovir Ophth Ointment 3 w w in 5 gm tube , D IFA RE 21 Ciprofloxacin HCl 0 DOT 3 Tube of 5 gm , D IFA RE 21 Ciprofloxacin HCl 0 DOT 3 Dexamethasone DOT 1 bott of 5ml , D IFA RE 21 Cyclosporine eye drop 0 DOT 05 bott of 3 ml , D IFA RE 21 Fluorescein Sodium 20 3 ml Inj , D IFA RE 21 Flurbiprofen Sodium ophthalmic soln 0 DOT 03 vial of 5 ml , D IFA RE 21 Homatropine Hydrochloride Soln 2 , D IFA RE 21 Ketorolac Tromethamine 0 DOT 4 Eye drops , D IFA RE 21 Natamycin 3 eye drops in 3 ml bott , D IFA RE 21 Carboxy Methyl Cellulose CMC 1 Gel , D IFA RE 21 Ofloxacin 0 DOT 3 bott of 5 ml , D IFA RE 21 Pilocarpine Nitrate eye solution 2 bott of 5 ml , D IFA RE 21 Pilocarpine Intracameral Inj 0 DOT 5 Pilocarpine nitrate intra ocular Inj without preservatives amp of 01ml each , D IFA RE 21 Prednisolone acetate 1 w v bott of 5 ml , D IFA RE 21 Sodium Chloride 6 w w ointment Tube of 3 gm , D IFA RE 21 Azelaic acid 20 cream tube of 15 gm , D IFA RE 21 Cream Luliconazole tube of 15 gm , D IFA RE 21 Tobramycin 0 DOT 3 bott of 5 ml , D IFA RE 21 Tropicamide 1 with 5 Phenylephrine eye drops bott of 5 ml , D IFA RE 21 Tropicamide Eye solution 1 bott of 5 ml , D IFA RE 21 Trypan Blue 0 DOT 6 Inj in vial of 1ml , D IFA RE 21 Amphotericin B 0 DOT 5 eye drops bott of 5 ml , D IFA RE 21 Atropine Sulphate 1 w v Eye Drop Bott of 3 ml , D IFA RE 21 Atropine Sulphate Oint 1 Tube of 3gm , D IFA RE 21 Olopatadine Hydrochloride 0 DOT 1 Ophthalmic Soln Bott of 5ml , D IFA RE 21 Olopatadine 0 DOT 2 Ophthalmic Soln bott of 5 ml , D IFA RE 21 Proparacaine Eye Drops 0 DOT 5 Bott of 5 ml , D IFA RE 21 Moxifloxacin HCl 0 DOT 5 and Dexamethasone 0 DOT 1 Ophthalmic Soln Bott of 5ml , D IFA RE 21 Diphenhydramine 10 15 mg per 5 ml and Ammonium Chloride 100 150 mg Sodium Citrate 50 85 mg per 5ml Syp Bott of 100ml , D IFA RE 21 Beclomethasone Dipropionate nasal spray 50 mcg per dose metered dose 150 units , D IFA RE 21 Betahistine Dihydrochloride 16mg Tab , D IFA RE 21 Clotrimazole 1 w v IP Lignocaine 2 w v IP ear drop bott of 10ml , D IFA RE 21 Chloramphenicol 5 w v Clotrimazole 1 w v Betamethasone 0 DOT 25 w v Lignocaine HCl 2 w v in bott of 5 ml , D IFA RE 21 Xylometazoline HCl 0 DOT 05 w v nasal solution for paed use bott of 10ml
April 30, 2025
May 22, 2025 at 10:00 AM
View Details

SYNDOPA PLUS 125 MG TAB,ZOLPIDEM 5 MG TAB,CALAMINE 8 PERCENTAGE LOTION 100 ML,ALFUZOSIN 10 MG TAB,S

GEM
Goods
Qty:17.8K
4 Files
Indian Navy
MUMBAI, MAHARASHTRA
Boq › Boql
SYNDOPA PLUS 125 MG TAB , ZOLPIDEM 5 MG TAB , CALAMINE 8 PERCENTAGE LOTION 100 ML , ALFUZOSIN 10 MG TAB , SEVELAMER 400 MG TAB
April 30, 2025
May 22, 2025 at 9:00 AM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered pharmaceutical entity or manufacturer. Bidders must comply with all applicable laws and possess prior experience in supplying similar medical products. Additionally, financial stability and the ability to fulfill the order quantity are vital for eligibility.

Bidders must ensure that all products comply with the latest pharmacopoeia standards. This includes providing quality assurance certificates and demonstrating the efficacy of the medications. Detailed product specifications, labeling, and quality compliance documentation must also be included with the bid.

All bidders are required to submit an Earnest Money Deposit (EMD) along with their bid to secure their offer. This deposit is an assurance of the bidder’s commitment and typically varies based on the tender’s financial scope. Please refer to the tender documentation for the specific EMD amount and payment method.

Bids must be submitted electronically via the designated bidder portal. Bidders should ensure that both technical and financial documents are uploaded correctly, adhering to any prescribed formats mentioned in the tender documentation. Late submissions may not be considered.

The tender accommodates Micro, Small, and Medium Enterprises (MSEs) with potential benefits such as relaxed eligibility criteria and additional evaluation considerations. Startups are also encouraged to participate and may receive specific privileges outlined in the tender details. Compliance with ‘Make in India’ policies will be an essential factor.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders